CONTRATOS DE INVESTIGACIÓN
Contract 46/1996
EFECTOS DEL GCSF (FILGASTRIM) SOBRE LA FUNCION DE LAS CELULAS MONONUCLEARES DE SANGRE PERIFERICA DE PACIENTES CON CANCER DE MAMA (PRORROGA DEL SUSCRITO EN 1995)
Funder:
AMGEN, S.A.
date_range
Duration: from 01 July 1996 to 01 January 1997
(6 months)
Finished
Of National scope. It has been granted under a regime of Direct grant.
Call:
(AMGEN, S.A.)